Multi-omics for COVID-19: driving development of therapeutics and vaccines

Author:

Guo Mengyu1,Xiong Muya23,Peng Jinying4,Guan Tong13,Su Haixia23,Huang Yanyi5678ORCID,Yang Cai-Guang93,Li Yang10,Boraschi Diana1011,Pillaiyar Thanigaimalai12,Wang Guanbo56,Yi Chengqi4137,Xu Yechun23ORCID,Chen Chunying1314ORCID

Affiliation:

1. CAS Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety, and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China , Beijing 100190 , China

2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China

3. University of Chinese Academy of Sciences , Beijing 100049 , China

4. State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University , Beijing 100871 , China

5. Biomedical Pioneering Innovation Centre, Peking University , Beijing 100871 , China

6. Institute for Cell Analysis, Shenzhen Bay Laboratory , Shenzhen 528107 , China

7. Peking-Tsinghua Center for Life Sciences, Peking University , Beijing 100871 , China

8. College of Chemistry and Molecular Engineering, Beijing National Laboratory for Molecular Sciences, Peking University , Beijing 100871 , China

9. State Key Laboratory of Drug Research, Centre for Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203 , China

10. Laboratory of Immunology and Nanomedicine, and China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences , Shenzhen 518055 , China

11. Institute of Biochemistry and Cell Biology , National Research Council, Napoli 80131 , Italy

12. Institute of Pharmacy, Pharmaceutical/Medicinal Chemistry and Tuebingen Center for Academic Drug Discovery, Eberhard Karls University Tübingen , Tübingen 72076 , Germany

13. Department of Chemical Biology and Synthetic and Functional Biomolecules Center, College of Chemistry and Molecular Engineering, Peking University , Beijing 100871 , China

14. GBA National Institute for Nanotechnology Innovation , Guangzhou 510700 , China

Abstract

ABSTRACT The ongoing COVID-19 pandemic caused by SARS-CoV-2 has raised global concern for public health and economy. The development of therapeutics and vaccines to combat this virus is continuously progressing. Multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, epigenomics and metallomics, have helped understand the structural and molecular features of the virus, thereby assisting in the design of potential therapeutics and accelerating vaccine development for COVID-19. Here, we provide an up-to-date overview of the latest applications of multi-omics technologies in strategies addressing COVID-19, in order to provide suggestions towards the development of highly effective knowledge-based therapeutics and vaccines.

Funder

Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Chinese Academy of Sciences

Publisher

Oxford University Press (OUP)

Subject

Multidisciplinary

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3